(Q53098366)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24336158%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

title

Loss of ARID1A expression and its relationship with PI3K-Akt pathway alterations and ZNF217 amplification in ovarian clear cell carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24336158%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24336158%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Kuan-Ting Kuo

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24336158%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

author name string

Hsien-Neng Huang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24336158%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Ming-Chieh Lin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24336158%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Wen-Chih Huang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24336158%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

publication date

13 December 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24336158%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24336158%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24336158%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24336158%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

page(s)

983-990

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24336158%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/modpathol.2013.216

3 March 2020

exact match

0 references

cites work

Clear cell carcinoma of the ovary: a report from the first Ovarian Clear Cell Symposium, June 24th, 2010.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.216

Advanced stage clear-cell epithelial ovarian cancer: the Hellenic Cooperative Oncology Group experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.216

The human SWI-SNF complex protein p270 is an ARID family member with non-sequence-specific DNA binding activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.216

Reconstitution of a core chromatin remodeling complex from SWI/SNF subunits

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.216

ARID1A mutations in endometriosis-associated ovarian carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.216

Does the Loss of ARID1A (BAF-250a) Expression in Endometrial Clear Cell Carcinomas Have Any Clinicopathologic Significance? A Pilot Assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.216

Frequent low expression of chromatin remodeling gene ARID1A in breast cancer and its clinical significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.216

Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.216

Decreased expression of the ARID1A gene is associated with poor prognosis in primary gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.216

Clinicopathological significance of loss of ARID1A immunoreactivity in ovarian clear cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.216

Frequent activating mutations of PIK3CA in ovarian clear cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.216

DNA copy numbers profiles in affinity-purified ovarian clear cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.216

The importance of the PI3K/AKT/MTOR pathway in the progression of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.216

Morphologic spectrum of immunohistochemically characterized clear cell carcinoma of the ovary: a study of 155 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.216

A limited panel of immunomarkers can reliably distinguish between clear cell and high-grade serous carcinoma of the ovary

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.216

Pathogenesis and the role of ARID1A mutation in endometriosis-related ovarian neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.216

Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.216

Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.216

The biology of chromatin remodeling complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.216

ARID1A, a factor that promotes formation of SWI/SNF-mediated chromatin remodeling, is a tumor suppressor in gynecologic cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.216

PIK3CA mutations and loss of ARID1A protein expression are early events in the development of cystic ovarian clear cell adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.216

Loss of ARID1A protein expression occurs as an early event in ovarian clear-cell carcinoma development and frequently coexists with PIK3CA mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.216

ZNF217 suppresses cell death associated with chemotherapy and telomere dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.216

ZNF217, a candidate breast cancer oncogene amplified at 20q13, regulates expression of the ErbB3 receptor tyrosine kinase in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.216

Prognostic and therapeutic impact of the chromosome 20q13.2 ZNF217 locus amplification in ovarian clear cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.216

Loss of ARID1A/BAF250a expression is linked to tumor progression and adverse prognosis in cervical cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.216

Clinicopathologic and biological analysis of PIK3CA mutation in ovarian clear cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.216

The clinical effect of the dual-targeting strategy involving PI3K/AKT/mTOR and RAS/MEK/ERK pathways in patients with advanced cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.216

Sequence mutations and amplification of PIK3CA and AKT2 genes in purified ovarian serous neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.216

7 January 2021

PTEN expression in clear cell adenocarcinoma of the ovary

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.216

7 January 2021

Loss of ARID1A expression and its relationship with PI3K-Akt pathway alterations, TP53 and microsatellite instability in endometrial cancer.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.216

7 January 2021

Loss of ARID1A expression is related to shorter progression-free survival and chemoresistance in ovarian clear cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.216

7 January 2021

PTEN promoter methylation and LOH of 10q22-23 locus in PTEN expression of ovarian clear cell adenocarcinomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.216

7 January 2021

10.1038/MODPATHOL.2013.216

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24336158%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

1 reference